Sildenafil Powder, For Suspension
Product Images NDC 60219-2651

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 60219-2651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Sildenafil Powder For Oral Suspension 1)

1 (Sildenafil Powder For Oral Suspension 1)
This text provides guidance on drug interactions with Atorvastatin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. It indicates whether dose adjustment is needed for specific drugs when co-administered. The information includes data on fold change, 90% CI recommendations, and effects on AUC and Cmax values for various medications. It mentions that no benefit on exercise capacity is seen when adding sildenafil to bosentan therapy.*
FDA Label Image

E (Sildenafil Powder For Oral Suspension 10)

FDA Label Image

F (Sildenafil Powder For Oral Suspension 11)

FDA Label Image

G (Sildenafil Powder For Oral Suspension 12)

FDA Label Image

H (Sildenafil Powder For Oral Suspension 13)

FDA Label Image

I (Sildenafil Powder For Oral Suspension 14)

FDA Label Image

1 (Sildenafil Powder For Oral Suspension 15)

1 (Sildenafil Powder For Oral Suspension 15)
This text contains information about sildenafil suspension before reconstitution. It mentions that each bottle contains 1.57g of sildenafil citrate. The suspension should be stored below 30°C, protected from moisture, not be frozen, and any unused portion should be discarded after 60 days. The usual dosage should be followed as per the prescribing information. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd. and the product is grape-flavored. The expiration date is listed as 02.2024-01.*
FDA Label Image

2 (Sildenafil Powder For Oral Suspension 16)

2 (Sildenafil Powder For Oral Suspension 16)
This text provides instructions for reconstituting a pharmaceutical suspension containing Sildenafil. It explains the process of adding water and shaking the bottle to ensure a uniform mixture. The recommended dosage and storage conditions are also mentioned. The product is specified for oral use only and each milliliter of the suspension contains 10 mg of Sildenafil. Manufacturing and distribution information is included at the end of the text.*
FDA Label Image

2 (Sildenafil Powder For Oral Suspension 2)

2 (Sildenafil Powder For Oral Suspension 2)
This text provides recommendations for drug interactions based on the fold change and 90% confidence intervals. It specifies advice for various drugs such as acenocoumarol, aspirin, atorvastatin, bosentan, doxazosin, ethinyl estradiol, and more. The text also includes specific adjustments or coadministration recommendations for different drugs.*
FDA Label Image

3 (Sildenafil Powder For Oral Suspension 3)

FDA Label Image

4 (Sildenafil Powder For Oral Suspension 4)

4 (Sildenafil Powder For Oral Suspension 4)
This text provides information on a study involving Placebo (Sildenafil) 20 mg taken three times a day for patients with pulmonary arterial hypertension (PAH). It includes median and mean values for various parameters such as age, pulmonary arterial pressure (PAP), and the 6-minute walk distance. The data is being presented for the placebo-corrected change in the 6-minute walk distance.*
FDA Label Image

5 (Sildenafil Powder For Oral Suspension 5)

FDA Label Image

A (Sildenafil Powder For Oral Suspension 6)

A (Sildenafil Powder For Oral Suspension 6)
This text appears to describe different components of a bottle adapter and barrel used for a sildenafil oral suspension. It mentions a plunger and provides a reference to Figure A for visual guidance.*
FDA Label Image

B (Sildenafil Powder For Oral Suspension 7)

FDA Label Image

C (Sildenafil Powder For Oral Suspension 8)

FDA Label Image

D (Sildenafil Powder For Oral Suspension 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.